Caitlynn Mirabelli

Caitlynn Mirabelli

Auto-generated profile, based on publicly available information

Caitlynn Mirabelli

Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2025 in Science Advances
Verified
Journal Article
Open access
JHJohn Heath
John Heath
RARyuhjin Ahn
Ryuhjin Ahn
VSValerie Sabourin
Valerie Sabourin
YIYoung Kyuen Im
Young Kyuen Im
SRSabrina Rezzara Richard
Sabrina Rezzara Richard
JUJosie Ursini-Siegel
Josie Ursini-Siegel
Although effective for immunologically hot tumors, immune checkpoint inhibitors minimally affect tumors that are not T cell inflamed, including breast cancer. An alternate strategy to combat immune cold breast tumors may be to reeducate innate immunity. This study identifies strategies to skew neutrophils to acquire tumoricidal properties. Systemic Toll-like receptor (TLR)–induced inflammation, concomitant with mitochondrial complex I inhibition in breast tumors, increases neutrophil cytotoxicity against breast cancer cells and independently of CD8+ T cell immunity. These therapy-entrained neutrophils enhance secretory granule production, increasing expression of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase machinery and inducing a respiratory burst. Moreover, systemic administration of TLR agonists elevates nuclear factor κB signaling in neutrophils to increase production of secretory granule and NADPH oxidase machinery components, whereas complex I inhibitors are required to potentiate oxidative damage. In summary, we describe a class of neutrophils, educated by the combined action of inflammatory mediators and metabolic inhibitors, having tumoricidal functions.

13 August 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JHJohn Heath
John Heath
CMCaitlynn Mirabelli
Caitlynn Mirabelli
MAMatthew G. Annis
Matthew G. Annis
VSValerie Sabourin
Valerie Sabourin
SHSteven Hebert
Steven Hebert
JUJosie Ursini-Siegel
Josie Ursini-Siegel
The pogo transposable element–derived zinc finger protein, POGZ, is notably associated with neurodevelopmental disorders through its role in gene transcription. Many proteins involved in neurological development are often dysregulated in cancer, suggesting a potential role for POGZ in tumor biology. Here, we provided experimental evidence that POGZ influences the growth and metastatic spread of triple-negative breast cancers (TNBC). In well-characterized models of TNBC, POGZ exerted a dual role, both as a tumor promoter and metastasis suppressor. Mechanistically, loss of POGZ potentiated TGFβ pathway activation to exert cytostatic effects while simultaneously increasing the mesenchymal and migratory properties of breast tumors. Although POGZ levels are elevated in human breast cancers, the most aggressive forms of TNBC tumors, including those with increased mesenchymal and metastatic properties, exhibit dampened POGZ levels, and low POGZ expression was associated with inferior clinical outcomes in these tumor types. Taken together, these data suggest that POGZ is a critical suppressor of the early stages of the metastatic cascade. Significance: The POGZ neurodevelopmental protein plays dual functions in triple-negative breast cancers as a tumor promoter and metastasis suppressor, inhibiting TGFβ-regulated EMT to limit breast cancer metastatic progression.

18 November 2024
Verified
Other
Open access
PDF file
JHJohn Heath
John Heath
CMCaitlynn Mirabelli
Caitlynn Mirabelli
MAMatthew G. Annis
Matthew G. Annis
VSValerie Sabourin
Valerie Sabourin
SHSteven Hebert
Steven Hebert
JUJosie Ursini-Siegel
Josie Ursini-Siegel
Supplemental Figure 3 with legend

18 November 2024
Verified
Other
Open access
PDF file
JHJohn Heath
John Heath
CMCaitlynn Mirabelli
Caitlynn Mirabelli
MAMatthew G. Annis
Matthew G. Annis
VSValerie Sabourin
Valerie Sabourin
SHSteven Hebert
Steven Hebert
JUJosie Ursini-Siegel
Josie Ursini-Siegel
Supplemental Figure 4 with Legend

18 November 2024
Verified
Other
Open access
PDF file
JHJohn Heath
John Heath
CMCaitlynn Mirabelli
Caitlynn Mirabelli
MAMatthew G. Annis
Matthew G. Annis
VSValerie Sabourin
Valerie Sabourin
SHSteven Hebert
Steven Hebert
JUJosie Ursini-Siegel
Josie Ursini-Siegel
Supplemental Figure 7 with legend

17 June 2026
Verified
Other
Open access
JHJohn Heath
John Heath
CMCaitlynn Mirabelli
Caitlynn Mirabelli
MAMatthew G. Annis
Matthew G. Annis
VSValerie Sabourin
Valerie Sabourin
SHSteven Hebert
Steven Hebert
JUJosie Ursini-Siegel
Josie Ursini-Siegel
Supplemental Figure 1 with legend